CompletedNCT01979679
Brain Imaging of Lurasidone’s Dopamine-Receptor Occupancy in Schizophrenia
About this title
Read the official source — NCT01979679Medication studyAges 18–60United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- OrangeSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateDecember 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 28
- Sponsor
- University of California, Irvine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT01979679
- Official title
Show the full official title
A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Orange
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, Irvine, a university.
Did this study involve medication?
Yes. The study involved medication, including Lurasidone 80 mg, Lurasidone 120 mg and Lurasidone 160 mg.
Who was this study for?
Listed age limits: 18 years to 60 years.
